BIOMAT Database Logo BIOMAT Database Logo

The influence of 1-(o-allylphenoxy)-3-isopropylamino-2-propanol hydrochloride (alprenolol) on the central nervous system of the rat. 1971

Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011941 Receptors, Adrenergic Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction. Adrenergic Receptors,Adrenoceptor,Adrenoceptors,Norepinephrine Receptor,Receptors, Epinephrine,Receptors, Norepinephrine,Adrenergic Receptor,Epinephrine Receptors,Norepinephrine Receptors,Receptor, Adrenergic,Receptor, Norepinephrine
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks

Related Publications

Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
May 1968, Archives internationales de pharmacodynamie et de therapie,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
Selective blockade of beta-adrenoceptors by 1-(p-allylphenoxy)-3-isopropylamino-2 propanol hydrochloride (h 64-52) in the anaesthetized dog.
February 1973, British journal of pharmacology,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
[Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
February 1968, Arzneimittel-Forschung,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
CNS effects of 1-isopropylamino-3-(4-indanoxy)-2-propanol hydrochloride (USVC-6524).
November 1972, Indian journal of experimental biology,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
[The effect of 1-(isopropylamino)-3-(m-toyloxy)-2-propanol hydrochloride (Doberol) on the bronchial system after oral administration].
June 1972, European journal of clinical pharmacology,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
August 1970, Arzneimittel-Forschung,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
July 1971, European journal of pharmacology,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
Cardiopulmonary actions of 1-isopropylamino-3-(3-tolyloxy)-2-propanol hydrochloride: a new adrenergic beta receptor antagonist.
February 1970, The Indian journal of medical research,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
Blockade of central beta-adrenergic receptors by tazolol (1-isopropylamino-3-(2-thiazoloxy)-2-propanol).
December 1977, Life sciences,
Z S Herman, and K Kmieciak-Kolada, and A Drybański, and A Sokola, and H Trzeciak, and T L Chruściel
[Optical antipodes of adrenergic beta receptor blocking agent 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol].
December 1970, Arzneimittel-Forschung,
Copied contents to your clipboard!